Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer

Stopped early

Conditions studied: Kidney Cancer

In brief

RATIONALE: Studying the genes and proteins expressed in tissue samples from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This laboratory study is evaluating gene and protein expression in normal tissue and tumor tissue from patients who have undergone surgery for kidney cancer.

Key facts

Study ID

NCT00899860

Run by

Wake Forest University Health Sciences

People needed

30

Starts

2003-09-01

Expected to finish

2012-06-01

Last updated by the study team

2017-05-30

Who can join

Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed renal cell cancer
• Clinical staging (if available)
• Underwent nephrectomy for renal cell cancer

Where it is running

• Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.